IVOO - ETF AI Analysis

Top Page

Vanguard S&P Mid-Cap 400 ETF (IVOO)

Rating:70Neutral

Price Target:―

The Vanguard S&P Mid-Cap 400 ETF (IVOO) has a solid overall rating, reflecting a mix of strong-performing holdings and some areas of caution. Top contributors include Comfort Systems USA (FIX), which benefits from robust revenue growth and strategic acquisitions, and United Therapeutics (UTHR), which shows strong profitability and promising strategic initiatives. However, holdings like Lumentum Holdings (LITE) and Pure Storage (PSTG) face challenges such as high valuations and bearish technical signals, which may weigh on the fund’s overall performance. A potential risk for this ETF is its exposure to stocks with high valuations, which could be sensitive to market corrections.

Positive Factors

Broad Sector Diversification

The fund spreads its investments across many sectors, which helps reduce the impact if any one industry struggles.

Low Expense Ratio

The ETF charges relatively low fees, so more of the fund’s returns stay in investors’ pockets over time.

Generally Positive Recent Performance

The ETF has shown steady gains over the past month, three months, and year to date, indicating supportive recent momentum.

Negative Factors

Heavy U.S. Concentration

Almost all of the fund’s assets are invested in U.S. companies, offering very little geographic diversification.

Mixed Results Among Top Holdings

Several of the largest positions have been weak or lagging this year, which could weigh on future returns if the trend continues.

Meaningful Exposure to Cyclical Sectors

Significant allocations to areas like industrials, financials, and consumer cyclical stocks may make the fund more sensitive to economic slowdowns.

IVOO vs. SPDR S&P 500 ETF (SPY)

AUM3.12B

RegionNorth America

Expense Ratio0.07%

Beta0.93

IssuerVanguard

Inception DateSep 07, 2010

Dividend Yield1.27%

Asset ClassEquity

Index TrackedS&P Mid Cap 400

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume97,054

30 Day Avg. Volume78,340

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

133.61

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering401

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

IVOO Summary

IVOO is the Vanguard S&P Mid-Cap 400 ETF, which follows the S&P MidCap 400 Index of medium‑sized U.S. companies. These are firms that are past the startup stage but still have room to grow, spread across many sectors like industrials, technology, and financials. Well-known names in the fund include Twilio and Illumina. Someone might invest in IVOO to diversify beyond the biggest U.S. stocks and seek long-term growth from mid-sized companies. A key risk is that mid-cap stocks can be more volatile than large companies, so the ETF’s value can go up and down with the market.

How much will it cost me?The Vanguard S&P Mid-Cap 400 ETF (IVOO) has an expense ratio of 0.07%, which means you’ll pay $0.70 per year for every $1,000 invested. This is lower than average because it is a passively managed fund that tracks the S&P MidCap 400 Index, keeping costs down for investors.

What would affect this ETF?IVOO's focus on mid-sized U.S. companies positions it to benefit from economic growth and innovation, particularly in sectors like Industrials and Technology, which are heavily weighted in the ETF. However, rising interest rates or economic slowdowns could negatively impact mid-cap stocks, especially in cyclical sectors like Consumer Cyclical and Financials. Regulatory changes or sector-specific challenges in industries such as Health Care or Real Estate may also influence performance.

IVOO Top 10 Holdings

IVOO’s story right now is all about U.S. mid-cap innovators, with a clear tilt toward tech and industrial names. Optical and communications players like Ciena and Coherent have been rising, giving the fund a helpful tailwind, while Illumina has also added spark from the health care side. On the flip side, Twilio has been losing steam and Lumentum’s choppy path has kept returns a bit bumpier. Overall, performance is being driven by a cluster of mid-cap tech and industrial leaders rather than any single dominant stock.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
CIEN	Ciena	1.02%	$49.00M	$33.98B	136.19%	70 Outperform
COHR	Coherent Corp	0.90%	$43.08M	$30.40B	86.61%	66 Neutral
LITE	Lumentum Holdings	0.81%	$38.82M	$25.30B	261.07%	61 Neutral
FLEX	Flex	0.69%	$33.19M	$23.82B	49.80%	74 Outperform
TWLO	Twilio	0.67%	$32.03M	$18.15B	6.76%	70 Neutral
UTHR	United Therapeutics	0.65%	$31.16M	$20.15B	26.32%	79 Outperform
PSTG	Pure Storage	0.65%	$31.07M	$23.13B	-0.79%	64 Neutral
CASY	Casey's General	0.64%	$30.53M	$23.67B	53.37%	68 Neutral
CW	Curtiss-Wright	0.63%	$30.20M	$23.98B	73.11%	74 Outperform
ILMN	Illumina	0.62%	$29.77M	$22.49B	8.63%	71 Outperform

IVOO Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

112.77

Positive

100DMA

111.35

Positive

200DMA

106.72

Positive

Market Momentum

MACD

1.72

Negative

RSI

66.02

Neutral

STOCH

67.74

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IVOO, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 115.92, equal to the 50-day MA of 112.77, and equal to the 200-day MA of 106.72, indicating a bullish trend. The MACD of 1.72 indicates Negative momentum. The RSI at 66.02 is Neutral, neither overbought nor oversold. The STOCH value of 67.74 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IVOO.

IVOO Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
IVOO	―	―	$3.12B	0.07%	―
IJH	―	―	$109.01B	0.05%	―
MDY	―	―	$25.20B	0.24%	―
SPMD	―	―	$16.12B	0.03%	―
XMHQ	―	―	$5.39B	0.25%	―
XMMO	―	―	$5.32B	0.35%	―

Performance Comparison

IVOO

Vanguard S&P Mid-Cap 400 ETF

119.10

9.74

8.91%

IJH

iShares Core S&P Mid-Cap ETF

―

MDY

SPDR S&P Midcap 400 ETF Trust

―

SPMD

SPDR Portfolio S&P 400 Mid Cap ETF

―

XMHQ

Invesco S&P MidCap Quality ETF

―

XMMO

Invesco S&P MidCap Momentum ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents